Disease-Associated α-Synuclein Aggregates as Biomarkers of Parkinson Disease Clinical Stage
<h3>Background and Objectives</h3><p dir="ltr">Robust biomarkers that can mirror Parkinson disease (PD) are of great significance. In this study, we present a novel approach to investigate disease-associated α-synuclein (αSyn) aggregates as biomarkers of PD clinical stage...
محفوظ في:
| المؤلف الرئيسي: | Nour Majbour (3528548) (author) |
|---|---|
| مؤلفون آخرون: | Jan Aasly (3540158) (author), Ilham Abdi (18394764) (author), Simona Ghanem (8548050) (author), Daniel Erskine (3471959) (author), Wilma van de Berg (3554690) (author), Omar El-Agnaf (2134222) (author) |
| منشور في: |
2022
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease
حسب: Luis M. A. Oliveira (18459000)
منشور في: (2021) -
Natural Alkaloid Compounds as Inhibitors for Alpha-Synuclein Seeded Fibril Formation and Toxicity
حسب: Simona S. Ghanem (12267227)
منشور في: (2021) -
RT-QuIC Using C-Terminally Truncated α-Synuclein Forms Detects Differences in Seeding Propensity of Different Brain Regions from Synucleinopathies
حسب: Ilaria Poggiolini (296742)
منشور في: (2021) -
Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer’s disease
حسب: Nour K. Majbour (8809316)
منشور في: (2017) -
Assessment of Aggregated and Exosome-Associated α-Synuclein in Brain Tissue and Cerebrospinal Fluid Using Specific Immunoassays
حسب: Dimitrios Anagnostou (18000752)
منشور في: (2023)